ZIVO BIOSCIENCE, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
ZIVO BIOSCIENCE, INC. (ZIVO) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$1.49 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2025-11-14
- ZIVO BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$1.03M.
- ZIVO BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$135.74K.
- ZIVO BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$1.59M.
- ZIVO BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2022-03-31 was -$2.30M, a 2547.96% decline year-over-year.
- ZIVO BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $1.27M.
- ZIVO BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$1.52M.
- ZIVO BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$7.10M, a 181.04% decline from fiscal 2021.
- ZIVO BIOSCIENCE, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was $8.76M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$1.49M 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | -$1.53M 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | -$1.03M 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | $1.27M 10-K · filed 2025-03-18 | |||
| 2024-09-30 | -$114.98K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | -$271.91K 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | -$135.74K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$1.52M 10-K · filed 2025-03-18 | |||
| 2023-09-30 | -$314.62K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$1.78M 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | -$1.59M 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | -$7.10M 10-K · filed 2024-03-15 | |||
| 2022-09-30 | -$5.52M 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | -$3.82M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | -$2.30M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $8.76M 10-K · filed 2023-03-14 | |||
| 2021-09-30 | $10.67M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $10.77M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | $94.07K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | -$208.25K 10-K · filed 2022-04-22 | |||
| 2020-09-30 | -$290.74K 10-Q/A · filed 2022-04-21 |